13725-02-5 Usage
Uses
Used in Pharmaceutical Industry:
3-AMINO-1-BENZYL-PIPERIDINE-3-CARBOXYLIC ACID is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure allows it to be a key component in the synthesis of various organic compounds with potential therapeutic effects.
Used in Organic Synthesis:
3-AMINO-1-BENZYL-PIPERIDINE-3-CARBOXYLIC ACID is used as a building block in organic synthesis for creating a wide range of chemical compounds. Its versatile functional groups enable it to participate in various chemical reactions, leading to the formation of new molecules with different properties and applications.
Used in Research and Development:
3-AMINO-1-BENZYL-PIPERIDINE-3-CARBOXYLIC ACID is used as a research compound in academic and industrial laboratories. It serves as a valuable tool for studying the structure-activity relationships of various biologically active molecules and for exploring new chemical reactions and synthetic pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 13725-02-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,2 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 13725-02:
(7*1)+(6*3)+(5*7)+(4*2)+(3*5)+(2*0)+(1*2)=85
85 % 10 = 5
So 13725-02-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O2/c14-13(12(16)17)7-4-8-15(10-13)9-11-5-2-1-3-6-11/h1-3,5-6H,4,7-10,14H2,(H,16,17)
13725-02-5Relevant articles and documents
PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS
-
, (2021/02/19)
The present invention provides a compound of Formula (I): (I) or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).
INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE
-
Page/Page column 148; 149, (2008/06/13)
The present invention relates to compounds that are selective and/or potent inhibitors of UPPS. In addition to compounds which inhibit UPPS, the invention also provides pharmaceutical compositions comprising these compounds and methods of using these comp